The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
The effects of Δ9-tetrahydrocannabinol on the dopamine system
Open accessAbstract
The effects of Δ9-tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, are a pressing concern for global mental health. Patterns of cannabis use are changing drastically owing to legalization, the availability of synthetic analogues (commonly termed spice), cannavaping and an emphasis on the purported therapeutic effects of cannabis. Many of the reinforcing effects of THC are mediated by the dopamine system. Owing to the complexity of the cannabinoid–dopamine interactions that take place, there is conflicting evidence from human and animal studies concerning the effects of THC on the dopamine system. Acute THC administration causes increased dopamine release and neuron activity, whereas long-term use is associated with blunting of the dopamine system. Future research must examine the long-term and developmental dopaminergic effects of THC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pertwee, R. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 1,935
D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb11001.x · Cited by 1,290
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,080
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Self-citationEffects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
Self-citationRegional and cellular fractionation of working memory
Goldman-Rakic, P. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13473 · Cited by 812
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Cannabinoid receptors and their ligands
Pertwee, R. G., & Ross, R. A. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0341 · Cited by 561
Hardwiring the Brain: Endocannabinoids Shape Neuronal Connectivity
Berghuis, P., Rajnicek, A. M., Morozov, Y. M., Ross, R. A., Mulder, J., Urbán, G. M., Monory, K., Marsicano, G., Matteoli, M., Canty, A., et al. (2007) · Science · doi:10.1126/science.1137406 · Cited by 551
Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525
The acute effects of cannabinoids on memory in humans: a review
Ranganathan, M., & D’Souza, D. C. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0508-y · Cited by 525
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis
Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2006) · Addiction · doi:10.1111/j.1360-0443.2005.01322.x · Cited by 484
Real-time measurement of dopamine fluctuations after cocaine in the brain of behaving rats
Heien, M. L. A. V., Khan, A. S., Ariansen, J. L., Cheer, J. F., Phillips, P. E. M., Wassum, K. M., & Wightman, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504657102 · Cited by 482
Huestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.322 · Cited by 481
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4004 · Cited by 481
Mehmedic, Z., Chandra, S., Slade, D., Denham, H., Foster, S., Patel, A. S., Ross, S. A., Khan, I. A., & ElSohly, M. A. (2010) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2010.01441.x · Cited by 475
Di Forti, M., Sallis, H., Allegri, F., Trotta, A., Ferraro, L., Stilo, S. A., Marconi, A., La Cascia, C., Reis Marques, T., Pariante, C., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt181 · Cited by 470
Young adult sequelae of adolescent cannabis use: an integrative analysis.
Silins, E., Horwood, L. J., Patton, G. C., Fergusson, D. M., Olsson, C. A., Hutchinson, D. M., Spry, E., Toumbourou, J. W., Degenhardt, L., Swift, W., et al. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70307-4 · Cited by 443
Hypothalamic POMC neurons promote cannabinoid-induced feeding
Koch, M., Varela, L., Kim, J. G., Kim, J. D., Hernández-Nuño, F., Simonds, S. E., Castorena, C. M., Vianna, C. R., Elmquist, J. K., Morozov, Y. M., et al. (2015) · Nature · doi:10.1038/nature14260 · Cited by 434
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Wong, C., Hitzemann, R., & Pappas, N. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35115-8 · Cited by 422
Self-citationThe neurobiology and evolution of cannabinoid signalling
Elphick, M. R., & Egertova, M. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2000.0787 · Cited by 417
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
Bossong, M. G., van Berckel, B. N., Boellaard, R., Zuurman, L., Schuit, R. C., Windhorst, A. D., van Gerven, J. M. A., Ramsey, N. F., Lammertsma, A. A., & Kahn, R. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.138 · Cited by 392
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
Kathmann, M., Flau, K., Redmer, A., Tränkle, C., & Schlicker, E. (2006) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-006-0033-x · Cited by 377
Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
French, E. D., Dillon, K., & Wu, X. (1997) · NeuroReport · doi:10.1097/00001756-199702100-00014 · Cited by 374
Kearn, C. S., Blake-Palmer, K., Daniel, E., Mackie, K., & Glass, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006882 · Cited by 359
Chen, J., Paredes, W., Li, J., Smith, D., Lowinson, J., & Gardner, E. L. (1990) · Psychopharmacology · doi:10.1007/bf02245916 · Cited by 329
Pregnenolone Can Protect the Brain from Cannabis Intoxication
Vallée, M., Vitiello, S., Bellocchio, L., Hébert-Chatelain, E., Monlezun, S., Martin-Garcia, E., Kasanetz, F., Baillie, G. L., Panin, F., Cathala, A., et al. (2014) · Science · doi:10.1126/science.1243985 · Cited by 319
Crane, N. A., Schuster, R. M., Fusar-Poli, P., & Gonzalez, R. (2013) · Neuropsychology Review · doi:10.1007/s11065-012-9222-1 · Cited by 309
Cannabis and educational achievement
Fergusson, D. M., Horwood, L. J., & Beautrais, A. L. (2003) · Addiction · doi:10.1111/j.1360-0443.2003.00573.x · Cited by 302
What predicts incident use of cannabis and progression to abuse and dependence?
von Sydow, K., Lieb, R., Pfister, H., Höfler, M., & Wittchen, H.-U. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00102-3 · Cited by 301
Spicing things up: synthetic cannabinoids
Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3188-4 · Cited by 296
Andrews, Z. B., Erion, D., Beiler, R., Liu, Z.-W., Abizaid, A., Zigman, J., Elsworth, J. D., Savitt, J. M., DiMarchi, R., Tschöp, M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3890-09.2009 · Cited by 289
Maternal Cannabis Use Alters Ventral Striatal Dopamine D2 Gene Regulation in the Offspring
DiNieri, J. A., Wang, X., Szutorisz, H., Spano, S. M., Kaur, J., Casaccia, P., Dow-Edwards, D., & Hurd, Y. L. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.027 · Cited by 276
Felder, C. C., Veluz, J. S., Williams, H. L., Briley, E. M., & Matsuda, L. A. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09174-6 · Cited by 261
Hyperphagia in pre-fed rats following oral δ9-THC
Williams, C. M., Rogers, P. J., & Kirkham, T. C. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00170-x · Cited by 256
Leweke, F. M., Giuffrida, A., Koethe, D., Schreiber, D., Nolden, B. M., Kranaster, L., Neatby, M. A., Schneider, M., Gerth, C. W., Hellmich, M., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.025 · Cited by 240
French, E. D. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00278-4 · Cited by 236
Andén, N.-E. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb08912.x · Cited by 236
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
Di Forti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.020 · Cited by 234
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Alexoff, D., Logan, J., Jayne, M., Wong, C., & Tomasi, D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411228111 · Cited by 230
Self-citationSolinas, M., Justinova, Z., Goldberg, S. R., & Tanda, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03880.x · Cited by 228
Pistis, M., Ferraro, L., Pira, L., Flore, G., Tanganelli, S., Gessa, G. L., & Devoto, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03055-x · Cited by 227
Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication
Volkow, N. D., Gillespie, H., Mullani, N., Tancredi, L., Grant, C., Valentine, A., & Hollister, L. (1996) · Psychiatry Research: Neuroimaging · doi:10.1016/0925-4927(96)02817-x · Cited by 219
Self-citationDopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Bloomfield, M. A. P., Morgan, C. J. A., Egerton, A., Kapur, S., Curran, H. V., & Howes, O. D. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.027 · Cited by 215
Self-citationComparison of the subjective effects of Δ 9 -tetrahydrocannabinol and marijuana in humans
S., W., M., E., S., R., J., A., & Wit, H. D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1033-2 · Cited by 210
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
Borgwardt, S. J., Allen, P., Bhattacharyya, S., Fusar-Poli, P., Crippa, J. A., Seal, M. L., Fraccaro, V., Atakan, Z., Martin-Santos, R., O'Carroll, C., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.011 · Cited by 195
The Marihuana Problem: An Overview
MCGLOTHLIN, W. H., & WEST, L. J. (1968) · American Journal of Psychiatry · doi:10.1176/ajp.125.3.370 · Cited by 194
Mesolimbic dopaminergic decline after cannabinoid withdrawal
Diana, M., Melis, M., Muntoni, A. L., & Gessa, G. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10269 · Cited by 192
Lecca, S., Melis, M., Luchicchi, A., Muntoni, A. L., & Pistis, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.302 · Cited by 184
Behavioral analysis of marijuana effects on food intake in humans
Foltin, R. W., Brady, J. V., & Fischman, M. W. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90144-9 · Cited by 176
Cannabis induced dopamine release: an in-vivo SPECT study
Voruganti, L. N. P., Slomka, P., Zabel, P., Mattar, A., & Awad, A. G. (2001) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(01)00104-4 · Cited by 172
Long-term consequences of adolescent cannabinoid exposure in adult psychopathology
Renard, J., Krebs, M., Pen, G. L., & Jay, T. M. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00361 · Cited by 170
A Brain on Cannabinoids: The Role of Dopamine Release in Reward SeekingPreprint
Oleson, E. B., & Cheer, J. F. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012229 · Cited by 167
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
Fernández‐Ruiz, J., Hernández, M., & Ramos, J. A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00144.x · Cited by 163
Cannabis and depression: An integrative data analysis of four Australasian cohorts
Horwood, L. J., Fergusson, D. M., Coffey, C., Patton, G. C., Tait, R. J., Smart, D., Letcher, P., Silins, E., & Hutchinson, D. M. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.06.002 · Cited by 163
Marinelli, S., Marzo, V. D., Florenzano, F., Fezza, F., Viscomi, M. T., van der Stelt, M., Bernardi, G., Molinari, M., Maccarrone, M., & Mercuri, N. B. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301118 · Cited by 161
Jentsch, J. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00018-3 · Cited by 158
Chartoff, E. H., & Connery, H. S. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00116 · Cited by 154
Lindgren, J., Ohlsson, A., Agurell, S., Hollister, L. E., & Gillespie, H. K. (1981) · Psychopharmacology · doi:10.1007/bf00427095 · Cited by 153
Can recreational doses of THC produce significant dopamine release in the human striatum?
Stokes, P. R. A., Mehta, M. A., Curran, H. V., Breen, G. D., & Grasby, P. M. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.029 · Cited by 153
Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes.
Banerjee, S., Snyder, S. H., & Mechoulam, R. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30230-2 · Cited by 146
Bossong, M. G., Mehta, M. A., van Berckel, B. N. M., Howes, O. D., Kahn, R. S., & Stokes, P. R. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3915-0 · Cited by 146
Self-citationEgerton, A., Demjaha, A., McGuire, P. K., Mehta, M. A., & Howes, O. D. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.058 · Cited by 143
Self-citationChen, J., Paredes, W. M., Lowinson, J. H., & Gardner, E. L. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90739-g · Cited by 142
Ton, J. M. N. C., Gerhardt, G. A., Friedemann, M., Etgen, A. M., Rose, G., Sharpless, N. S., & Gardner, E. L. (1988) · Brain Research · doi:10.1016/0006-8993(88)90749-4 · Cited by 141
Deficits in striatal dopamine release in cannabis dependence
van de Giessen, E., Weinstein, J. J., Cassidy, C., Haney, M., Dong, Z., Ghazzaoui, R., Ojeil, N., Kegeles, L. S., Xu, X., Vadhan, N. P., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.21 · Cited by 138
Self-citationD’Souza, D. C., Braley, G., Blaise, R., Vendetti, M. S., Oliver, S., Pittman, B. P., Ranganathan, M., Bhakta, S. G., Zimolo, Z., Cooper, T. B., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1042-2 · Cited by 134
Poddar, M. K., & Dewey, W. L. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32131-2 · Cited by 128
Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography Study
Urban, N., Slifstein, M., Thompson, J. L., Xu, X., Girgis, R. R., Raheja, S., Haney, M., & Abi‐Dargham, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.018 · Cited by 120
Wu, X., & French, E. D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00140-9 · Cited by 116
Striatal dopamine release in schizophrenia comorbid with substance dependence
Thompson, J. L., Urban, N., Slifstein, M., Xu, X., Kegeles, L. S., Girgis, R. R., Beckerman, Y., Harkavy‐Friedman, J., Gil, R. B., & Abi‐Dargham, A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.109 · Cited by 115
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
Barkus, E., Morrison, P. D., Vuletic, D., Dickson, J. C., Ell, P. J., Pilowsky, L. S., Brenneisen, R., Holt, D. W., Powell, J. F., Kapur, S., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110382465 · Cited by 114
The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study
Bloomfield, M., Morgan, C. J. A., Kapur, S., Curran, H. V., & Howes, O. D. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3523-4 · Cited by 109
Self-citationZamberletti, E., Prini, P., Speziali, S., Gabaglio, M., Solinas, M., Parolaro, D., & Rubino, T. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.038 · Cited by 107
A comparison of some pharmacological actions of morphine and ?9-tetrahydrocannabinol in the mouse
Bloom, A. S., & Dewey, W. L. (1978) · Psychopharmacology · doi:10.1007/bf00426745 · Cited by 102
Mizrahi, R., Kenk, M., Suridjan, I., Boileau, I., George, T. P., McKenzie, K., Wilson, A. A., Houle, S., & Rusjan, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.347 · Cited by 101
Garriott, J. C., King, L., Forney, R. B., & Hughes, F. W. (1967) · Life Sciences · doi:10.1016/0024-3205(67)90232-9 · Cited by 95
Kolb, B. E., Gorny, G., Limebeer, C. L., & Parker, L. A. (2006) · Synapse · doi:10.1002/syn.20313 · Cited by 95
Leroy, C., Karila, L., Martinot, J., Lukasiewicz, M., Duchesnay, É., Comtat, C., Dollé, F., Benyamina, A., Artiges, É., Ribeiro, M. J., et al. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00356.x · Cited by 93
Cadoni, C., Valentini, V., & Chiara, G. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05503.x · Cited by 88
Sevy, S., Smith, G. S., Ma, Y., Dhawan, V., Chaly, T., Kingsley, P. B., Kumra, S., Abdelmessih, S., & Eidelberg, D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1075-1 · Cited by 83
Hooker, W. D., & Jones, R. T. (1987) · Psychopharmacology · doi:10.1007/bf00690920 · Cited by 82
Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge
Stokes, P. R. A., Egerton, A., Watson, B. J., Reid, A., Breen, G. D., Lingford-Hughes, A. R., Nutt, D., & Mehta, M. A. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.274 · Cited by 81
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana?
Varlet, V., Concha‐Lozano, N., Berthet, A., Plateel, G., Favrat, B., Cesare, M. D., Lauer, E., Augsburger, M. P., Thomas, A., & Giroud, C. (2016) · Scientific Reports · doi:10.1038/srep25599 · Cited by 80
Navarro, M. A., Fernández‐Ruíz, J., de Miguel, R., Hernández, M., Cebeira, M., & Ramos, J. A. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90059-y · Cited by 77
Involvement of the endocannabinoid system in reward processing in the human brain
van Hell, H. H., Jager, G., Bossong, M. G., Brouwer, A., Jansma, J. M., Zuurman, L., van Gerven, J., Kahn, R. S., & Ramsey, N. F. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2428-8 · Cited by 77
Jentsch, D., Verrico, C. D., Le, D., & Roth, R. H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00254-7 · Cited by 76
Romero, J., de Miguel, R., García‐Palomero, E., Fernández‐Ruíz, J., & Ramos, J. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00835-e · Cited by 75
Navarro, M. A., Fernández‐Ruíz, J., de Miguel, R., Hernández, M., Cebeira, M., & Ramos, J. A. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90241-k · Cited by 74
Behan, Á. T., Hryniewiecka, M., O’Tuathaigh, C. M. P., Kinsella, A., Cannon, M. D., Karayiorgou, M., Gogos, J. A., Waddington, J. L., & Cotter, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.24 · Cited by 72
Paule, M. G., Allen, R. R., Bailey, J. R., Scallet, A. C., Ali, S. F. A., Brown, R. M., & Slikker, W. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11218-4 · Cited by 70
Acute effects of δ-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas
de Fonseca, F. R., Fernández‐Ruíz, J., Murphy, L. L., Cebeira, M., Steger, R. W., Artke, J. A., & Ramos, J. A. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90526-l · Cited by 69
Adolescent Δ9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats
Scherma, M., Dessì, C., Muntoni, A. L., Lecca, S., Satta, V., Luchicchi, A., Pistis, M., Panlilio, L. V., Fattore, L., Goldberg, S. R., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.295 · Cited by 66
Cadoni, C., Simola, N., Espa, E., Fenu, S., & Chiara, G. D. (2013) · Addiction Biology · doi:10.1111/adb.12085 · Cited by 64
Stokes, P. R., Egerton, A., Watson, B., Reid, A., Lappin, J., Howes, O. D., Nutt, D. J., & Lingford-Hughes, A. R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111414090 · Cited by 63
Self-citationSpiga, S., Lintas, A., Migliore, M., & Diana, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00218.x · Cited by 62
Albrecht, D., Skosnik, P. D., Vollmer, J. M., Brumbaugh, M. S., Perry, K. M., Mock, B. H., Zheng, Q., Federici, L. M., Patton, E. A., Herring, C. M., et al. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.016 · Cited by 61
Luca, M. A. D., Valentini, V., Bimpisidis, Z., Cacciapaglia, F., Caboni, P., & Chiara, G. D. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00140 · Cited by 58
Wiers, C., Shokri-Kojori, E., Wong, C. T., Abi-Dargham, A., Demiral, Ş., Tomasi, D., Wang, G.-J., & Volkow, N. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.67 · Cited by 58
Self-citationTHC does not affect striatal dopamine release: Microdialysis in freely moving rats
Castañeda, E., Moss, D. E., Oddie, S., & Whishaw, I. Q. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90367-b · Cited by 55
Ginovart, N., Tournier, B., Moulin-Sallanon, M., Steimer, T., Ibáñez, V., & Millet, P. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.91 · Cited by 55
Perinatal exposure to cannabinoids alters neurochemical development in rat brain
Walters, D. E., & Carr, L. A. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90300-0 · Cited by 53
Bonnin, A., de Miguel, R., Hernández, M., Ramos, J. A., & Fernández‐Ruíz, J. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00205-k · Cited by 50
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
Mizrahi, R., Suridjan, I., Kenk, M., George, T. P., Wilson, A. A., Houle, S., & Rusjan, P. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.232 · Cited by 50
The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol
Verty, A. N. A., McGregor, I. S., & Mallet, P. E. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.033 · Cited by 49
Nava, F. A., Carta, G., & Gessa, G. L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00231-8 · Cited by 46
Mokler, D. J., Robinson, S. E., Johnson, J. H., et al. (1987) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(87)90023-7 · Cited by 44
Avraham, Y., Ben‐Shushan, D., Breuer, A., Zolotarev, O., Okon, A., Fink, N., Katz, V., & Berry, E. M. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.01.015 · Cited by 44
Tunbridge, E. M., Dunn, G., Murray, R. M., Evans, N., Lister, R., Stumpenhorst, K., Harrison, P. J., Morrison, P. D., & Freeman, D. H. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115609073 · Cited by 44
Maclean, K. I., & Littleton, J. M. (1977) · European Journal of Pharmacology · doi:10.1016/0014-2999(77)90206-0 · Cited by 34
Hershkowitz, M., & Szechtman, H. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90290-5 · Cited by 34
Karch, S. B. (2007) · CRC Press eBooks · doi:10.1201/9781420054446-12 · Cited by 33
Bosier, B., Muccioli, G. G., Mertens, B., Sarre, S., Michotte, Y. M., Lambert, D. M., & Hermans, E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.003 · Cited by 31
Garcı́a-Gil, L., de Miguel, R., Muñoz, R. M., Cebeira, M., Villanúa, M. A., Ramos, J. A., & Fernández‐Ruíz, J. (1997) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(97)00048-2 · Cited by 28
Edible Cannabis Products: It Is Time for FDA Oversight
Benjamin, D. M., & Fossler, M. J. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.778 · Cited by 28
Disposition of smoked cannabis with high Δ9-tetrahydrocannabinol content: A kinetic model
Hunault, C. C., van Eijkeren, J. C. H., Mensinga, T. T., de Vries, I., Leenders, M. E. C., & Meulenbelt, J. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.04.019 · Cited by 26
Gifford, A. N., Gardner, E. L., & Ashby, C. R. (2008) · Neuropsychobiology · doi:10.1159/000119369 · Cited by 25
CANNABIS, CATECHOLAMINES, RAPID EYE MOVEMENT SLEEP AND AGGRESSIVE BEHAVIOUR
Carlini, E. A., Lindsey, C. J., & Tufik, S. B. (1977) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1977.tb08429.x · Cited by 24
Cortright, J. J., Lorrain, D. S., Beeler, J. A., Tang, W., & Vezina, P. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180208 · Cited by 20
Do we need an ethics of self-organizing tissue?
(2015) · Nature Methods · doi:10.1038/nmeth.3618 · Cited by 2
Cited by
The Neuroscience of Drug Reward and Addiction
Volkow, N. D., Michaelides, M., & Baler, R. (2019) · Physiological Reviews · doi:10.1152/physrev.00014.2018 · Cited by 863
Self-citationCannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
One Is Not Enough: Understanding and Modeling Polysubstance Use
Crummy, E. A., O’Neal, T. J., Baskin, B. M., & Ferguson, S. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00569 · Cited by 351
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Busquets-Garcia, A., Bains, J., & Marsicano, G. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.206 · Cited by 337
Non-Genetic Factors in Schizophrenia
Stilo, S. A., & Murray, R. M. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1091-3 · Cited by 311
Metadata
- Authors
- Bloomfield, M. A. P., Ashok, A. H., Volkow, N. D., & Howes, O. D.
- Venue
- Nature
- Published
- 2016-11
- Volume
- 539
- Issue
- 7629
- Pages
- 369-377
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2554987321
- Cited by
- 373
- References
- 124
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.